ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
US Tech 100
18,152.00
-0.42%
Dow Jones
39,065.26
-1.53%
Brent Oil
81.29
-0.02%
Bitcoin
67,726.83
-0.29%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Cryptocurrencies
  4. COIN
  5. (Cryptocurrency:BCHSVETH)

  6. (Cryptocurrency:BCHSVETH) News

BCHSVETH

(BCHSVETH)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/23/20249:55PMPR Newswire (US)Azul and GOL Announce Codeshare AgreementNYSE:AZULAzul SA
05/23/20249:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
05/23/20249:52PMPR Newswire (Canada)Rappel du gobelet NÜTRL de la marque Sunscope au Canada
05/23/20249:50PMBusiness Wireセルトリオン、欧州委員会からオマリズマブ バイオシミラー「Omlyclo®（CT-P39）」の承認を取得 – 欧州初・唯一の承認
05/23/20249:49PMGlobeNewswire Inc.Imperial Announces Voting Results for the Election of DirectorsTSX:IIIImperial Metals Corporation
05/23/20249:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:JOBGEE Group Inc
05/23/20249:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:JOBGEE Group Inc
05/23/20249:49PMBusiness WireCelltrion riceve l'approvazione della Commissione europea per Omlyclo® (CT-P39), il primo e unico farmaco biosimilare di omalizumab approvato in Europa
05/23/20249:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARVNArvinas Inc
05/23/20249:48PMPR Newswire (US)LENNAR DFW DIVISION HOSTS HOPEKIDS EVENT FOR CHILDREN WITH LIFE-THREATENING MEDICAL CONDITIONS AT KIDZANIA USA
05/23/20249:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TMCWWTMC the Metals Company Inc
05/23/20249:44PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
05/23/20249:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PETWWWag Group Company
05/23/20249:44PMPR Newswire (Canada)Sunscope Recalls NÜTRL-Branded Tumbler Cup in Canada
05/23/20249:43PMPR Newswire (US)What made ASML so successful today: DIGITIMES Asia's Q&A with Dutch Journalist and author Marc Hijink
05/23/20249:42PMBusiness WireThe World's First Five-Terminal Flexible DC Transmission Project is Undergoing a Complete Overhaul
05/23/20249:37PMGlobeNewswire Inc.Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram
05/23/20249:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MDGLMadrigal Pharmaceuticals Inc
05/23/20249:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRPBaldwin Insurance Group Inc
05/23/20249:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRPBaldwin Insurance Group Inc
05/23/20249:31PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:INSEInspired Entertainment Inc
05/23/20249:31PMPR Newswire (US)IEHP's newly announced Community Wellness Center adds more heart to the city of San Bernardino
05/23/20249:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYPLPayPal Holdings Inc
05/23/20249:26PMBusiness WireCelltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
05/23/20249:21PMPR Newswire (US)/C O R R E C T I O N -- IDEAYA Biosciences, Inc./NASDAQ:IDYAIDEAYA Biosciences Inc
05/23/20249:20PMPR Newswire (Canada)TSX Venture Exchange Stock Maintenance Bulletins
05/23/20249:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYPLPayPal Holdings Inc
05/23/20249:19PMGlobeNewswire Inc.ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des JahresEU:ONWDOnward Medical NV
05/23/20249:19PMGlobeNewswire Inc.ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écouléeEU:ONWDOnward Medical NV
05/23/20249:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BYFCBroadway Financial Corp

Your Recent History

USOTC
TDRK
TideRock Companies (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
AFFU
Affluence (PK)
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
NVDA
NVIDIA
USOTC
VXIT
Virexit Technologies (PK)
USOTC
DPLS
DarkPulse (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
MVNT
Movement Industries (PK)
NASDAQ
FCEL
FuelCell Energy
USOTC
QEDN
QED Connect (PK)
USOTC
PSRU
Valiant Eagle (PK)
NASDAQ
NB
NioCorp Developments
AMEX
SPY
SPDR S&P 500
USOTC
UATG
Umbra Applied Technologies (PK)
USOTC
NLST
Netlist (QB)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved